Literature DB >> 10208496

Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine.

K Kugiyama1, S Sugiyama, N Ogata, H Oka, H Doi, Y Ota, H Yasue.   

Abstract

This study examined whether lysophosphatidylcholine (lysoPC), an atherogenic lipid, may stimulate production of O2*-, in cultured human endothelial cells. Production of O2*- was detected by bis-N-methylacridinium nitrate (lucigenin)-elicited chemiluminescence. LysoPC was found to induce burst production of O2*-, peaked at 2-4 min after the stimulation, in intact endothelial cells. LysoPC also stimulated NADH-dependent production of O2*- in particulate fraction of the cells, and the action of lysoPC was inhibited by diphenyliodonium. The results suggested that lysoPC stimulated production of O2*- partly through membrane-associated NADH-dependent O2*- production systems.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208496     DOI: 10.1016/s0021-9150(98)00288-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications.

Authors:  Giuseppe Maiolino; Valeria Bisogni; Giacomo Rossitto; Gian Paolo Rossi
Journal:  World J Cardiol       Date:  2015-10-26

2.  Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells.

Authors:  Nambi Aiyar; Jyoti Disa; Zhaohui Ao; Haisong Ju; Sandhya Nerurkar; Robert N Willette; Colin H Macphee; Douglas G Johns; Stephen A Douglas
Journal:  Mol Cell Biochem       Date:  2006-08-08       Impact factor: 3.396

3.  Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosis.

Authors:  Satoshi Hara; Namiko Kobayashi; Kazuo Sakamoto; Toshiharu Ueno; Shun Manabe; Yasutoshi Takashima; Juri Hamada; Ira Pastan; Akiyoshi Fukamizu; Taiji Matsusaka; Michio Nagata
Journal:  Am J Pathol       Date:  2015-06-11       Impact factor: 4.307

Review 4.  Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis.

Authors:  Sina Tavakoli; Reto Asmis
Journal:  Antioxid Redox Signal       Date:  2012-06-11       Impact factor: 8.401

5.  Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.

Authors:  Dallit Mannheim; Joerg Herrmann; Daniele Versari; Mario Gössl; Fredric B Meyer; Joseph P McConnell; Lilach O Lerman; Amir Lerman
Journal:  Stroke       Date:  2008-03-20       Impact factor: 7.914

Review 6.  Regulation of the cellular content of the organic osmolyte taurine in mammalian cells.

Authors:  Ian Henry Lambert
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

7.  Protective effects of EPA and deleterious effects of DHA on eNOS activity in Ea hy 926 cultured with lysophosphatidylcholine.

Authors:  Sylviane Tardivel; Aurélie Gousset-Dupont; Véronique Robert; Marie-Luce Pourci; Alain Grynberg; Bernard Lacour
Journal:  Lipids       Date:  2009-02-04       Impact factor: 1.880

8.  Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.

Authors:  Kirsi H Pietiläinen; Marko Sysi-Aho; Aila Rissanen; Tuulikki Seppänen-Laakso; Hannele Yki-Järvinen; Jaakko Kaprio; Matej Oresic
Journal:  PLoS One       Date:  2007-02-14       Impact factor: 3.240

9.  Oleoyl-lysophosphatidylcholine limits endothelial nitric oxide bioavailability by induction of reactive oxygen species.

Authors:  Andrijana Kozina; Stefan Opresnik; Michael Sze Ka Wong; Seth Hallström; Wolfgang F Graier; Roland Malli; Katrin Schröder; Kurt Schmidt; Saša Frank
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

10.  The dihydropyridine calcium channel blocker benidipine prevents lysophosphatidylcholine-induced endothelial dysfunction in rat aorta.

Authors:  Makoto Takayama; Kozo Yao; Michihito Wada
Journal:  J Biomed Sci       Date:  2009-06-26       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.